[1] Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of the obesity society and the American society of hypertension. J Clin Hypertens, 2013; 15, 14−33. doi:  10.1111/jch.12049
[2] Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation, 2021; 143, e984−e1010.
[3] Choukem SP, Dimala CA. BMI and diabetes risk in low-income and middle-income countries. Lancet, 2021; 398, 190−2. doi:  10.1016/S0140-6736(21)01425-2
[4] Kim T, Shin SH, Kim H, et al. Longitudinal BMI change and outcomes in chronic obstructive pulmonary disease: a nationwide population-based cohort study. Respir Res, 2024; 25, 150. doi:  10.1186/s12931-024-02788-0
[5] Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism, 2019; 92, 121−35. doi:  10.1016/j.metabol.2018.11.001
[6] Garcia III GR, Coleman NC, Pond ZA, et al. Shape of BMI-mortality risk associations: reverse causality and heterogeneity in a representative cohort of US adults. Obesity, 2021; 29, 755−66. doi:  10.1002/oby.23114
[7] Bhaskaran K, Dos-Santos-Silva I, Leon DA, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol, 2018; 6, 944−53. doi:  10.1016/S2213-8587(18)30288-2
[8] Liu SH, Cao WZ, Li ZQ, et al. Association between different adiposity measures and all-cause mortality risk among centenarians: a prospective cohort study. Clin Nutr, 2023; 42, 1219−26. doi:  10.1016/j.clnu.2023.04.023
[9] Di Angelantonio E, Bhupathiraju SN, Wormser D, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet, 2016; 388, 776−86. doi:  10.1016/S0140-6736(16)30175-1
[10] Kim HJ, Kim BS, Lee JH, et al. Impact of underweight on 3-year all-cause mortality in patients with acute severe hypertension: a retrospective cohort study. Sci Rep, 2022; 12, 4798. doi:  10.1038/s41598-022-08892-9
[11] Jerant A, Franks P. Body mass index, diabetes, hypertension, and short-term mortality: a population-based observational study, 2000-2006. J Am Board Fam Med, 2012; 25, 422−31. doi:  10.3122/jabfm.2012.04.110289
[12] Song R, Chen XJ, He K, et al. Associations of BMI with all-cause mortality in normoglycemia, impaired fasting glucose and type 2 diabetes mellitus among an elderly Chinese population: a cohort study. BMC Geriatr, 2022; 22, 690. doi:  10.1186/s12877-022-03382-z
[13] Lin CC, Li CI, Liu CS, et al. Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: retrospective cohort studies. Diabetes Metab, 2019; 45, 564−72. doi:  10.1016/j.diabet.2019.02.007
[14] Ji ZC, de Miguel-Díez J, Castro-Riera CR, et al. Differences in the outcome of patients with COPD according to body mass index. J Clin Med, 2020; 9, 710. doi:  10.3390/jcm9030710
[15] Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord, 2018; 23, 15−22. doi:  10.1007/s40519-017-0456-z
[16] Nowak MM, Niemczyk M, Gołębiewski S, et al. Impact of body mass index on all-cause mortality in adults: a systematic review and meta-analysis. J Clin Med, 2024; 13, 2305. doi:  10.3390/jcm13082305
[17] Department of Medical Administration, National Health Commission of the People’s Republic of China. Chinese guidelines for the clinical management of obesity (2024 Edition). Med J Peking Union Med College Hospital, 2025; 16, 90−108. (In Chinese)
[18] Lv YB, Zhang Y, Li XW, et al. Body mass index, waist circumference, and mortality in subjects older than 80 years: a Mendelian randomization study. Eur Heart J, 2024; 45, 2145−54. doi:  10.1093/eurheartj/ehae206
[19] Lv YB, Mao C, Gao X, et al. The obesity paradox is mostly driven by decreased noncardiovascular disease mortality in the oldest old in China: a 20-year prospective cohort study. Nat Aging, 2022; 2, 389−96. doi:  10.1038/s43587-022-00201-3
[20] Gao L, Lu W, Bai LQ, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015; 15, 310−9. doi:  10.1016/S1473-3099(14)71085-0
[21] Cheng FW, Gao X, Mitchell DC, et al. Body mass index and all-cause mortality among older adults. Obesity, 2016; 24, 2232−9. doi:  10.1002/oby.21612
[22] Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA, 2013; 309, 71−82. doi:  10.1001/jama.2012.113905
[23] Zhu YB, Wang Q, Pang GM, et al. Association between body mass index and health-related quality of life: the “obesity paradox” in 21, 218 adults of the Chinese general population. PLoS One, 2015; 10, e0130613. doi:  10.1371/journal.pone.0130613
[24] Shaikh SR, Beck MA, Alwarawrah Y, et al. Emerging mechanisms of obesity-associated immune dysfunction. Nat Rev Endocrinol, 2024; 20, 136−48. doi:  10.1038/s41574-023-00932-2
[25] Yeung SSY, Reijnierse EM, Pham VK, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle, 2019; 10, 485−500. doi:  10.1002/jcsm.12411
[26] Childers DK, Allison DB. The‘obesity paradox’: a parsimonious explanation for relations among obesity, mortality rate and aging?. Int J Obes, 2010; 34, 1231−8. doi:  10.1038/ijo.2010.71
[27] Bales CW, Buhr GT. Body mass trajectory, energy balance, and weight loss as determinants of health and mortality in older adults. Obes Facts, 2009; 2, 171−8. doi:  10.1159/000221008
[28] Ditillo M, Pandit V, Rhee P, et al. Morbid obesity predisposes trauma patients to worse outcomes: a national trauma data bank analysis. J Trauma Acute Care Surg, 2014; 76, 176−9. doi:  10.1097/TA.0b013e3182ab0d7c
[29] Winfield RD, Bochicchio GV. The critically injured obese patient: a review and a look ahead. J Am Coll Surg, 2013; 216, 1193−206. doi:  10.1016/j.jamcollsurg.2013.01.055
[30] Oreopoulos A, Kalantar-Zadeh K, Sharma AM, et al. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med, 2009; 25, 643−59. doi:  10.1016/j.cger.2009.07.005
[31] Xiao FH, Chen XQ, Yu Q, et al. Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians. Genome Res, 2018; 28, 1601−10. doi:  10.1101/gr.220780.117
[32] Passtoors WM, Beekman M, Deelen J, et al. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell, 2013; 12, 24−31. doi:  10.1111/acel.12015
[33] Sandhu RK, Ezekowitz J, Andersson U, et al. The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur Heart J, 2016; 37, 2869−78. doi:  10.1093/eurheartj/ehw124
[34] Lin GM, Li YH, Lin CL, et al. Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: a report from the ET-CHD registry. Int J Cardiol, 2013; 168, 616−20. doi:  10.1016/j.ijcard.2013.01.204
[35] Younis A, Younis A, Goldkorn R, et al. The association of body mass index and 20-Year all-cause mortality among patients with stable coronary artery disease. Heart Lung Circ, 2019; 28, 719−26. doi:  10.1016/j.hlc.2018.02.015